These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Clinical and neuropsychological correlates of cerebral ventricular enlargement in schizophrenia. Kemali D; Maj M; Galderisi S; Ariano MG; Cesarelli M; Milici N; Salvati A; Valente A; Volpe M J Psychiatr Res; 1985; 19(4):587-96. PubMed ID: 4078761 [TBL] [Abstract][Full Text] [Related]
44. Selective enlargement of the third ventricle found in chronic schizophrenia. Kanba S; Shima S; Masuda Y; Tsukumo T; Kitamura T; Asai M Psychiatry Res; 1987 May; 21(1):49-53. PubMed ID: 3602219 [TBL] [Abstract][Full Text] [Related]
45. Ventricular enlargement in young chronic schizophrenics. Obiols Llandrich JE; Ruscalleda J; Masferrer M Acta Psychiatr Scand; 1986 Jan; 73(1):42-4. PubMed ID: 3485888 [TBL] [Abstract][Full Text] [Related]
46. Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients. Shvartsburd A; Sajadi C; Morton V; Mirabi M; Gordon J; Smith RC J Clin Psychopharmacol; 1984 Aug; 4(4):194-8. PubMed ID: 6470190 [TBL] [Abstract][Full Text] [Related]
47. Cognitive impairment in schizophrenia: specific relations to ventricular size and negative symptomatology. Keilp JG; Sweeney JA; Jacobsen P; Solomon C; St Louis L; Deck M; Frances A; Mann JJ Biol Psychiatry; 1988 May; 24(1):47-55. PubMed ID: 3370277 [TBL] [Abstract][Full Text] [Related]
48. Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial. Gomez JC; Crawford AM J Clin Psychiatry; 2001; 62 Suppl 2():6-11. PubMed ID: 11232753 [TBL] [Abstract][Full Text] [Related]
49. Cerebral ventricular enlargement in subtypes of chronic schizophrenia. Nasrallah HA; Jacoby CG; McCalley-Whitters M; Kuperman S Arch Gen Psychiatry; 1982 Jul; 39(7):774-7. PubMed ID: 6984642 [TBL] [Abstract][Full Text] [Related]
50. Electrodermal activity and therapeutic response to neuroleptic treatment in chronic schizophrenic in-patients. Schneider SJ Psychol Med; 1982 Aug; 12(3):607-13. PubMed ID: 7134318 [TBL] [Abstract][Full Text] [Related]
51. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays. Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566 [TBL] [Abstract][Full Text] [Related]
52. Decreased slow-wave sleep and enlarged lateral ventricles in schizophrenia. van Kammen DP; van Kammen WB; Peters J; Goetz K; Neylan T Neuropsychopharmacology; 1988 Dec; 1(4):265-71. PubMed ID: 3251506 [TBL] [Abstract][Full Text] [Related]
53. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Tollefson GD; Beasley CM; Tran PV; Street JS; Krueger JA; Tamura RN; Graffeo KA; Thieme ME Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331 [TBL] [Abstract][Full Text] [Related]
54. A comparative trial of haloperidol and thioridazine: management of chronic schizophrenia. Weston MJ; Bentley R; Unwin A; Morris M; Harper MA Aust N Z J Psychiatry; 1973 Mar; 7(1):52-7. PubMed ID: 4579393 [No Abstract] [Full Text] [Related]
55. Relationship between brain imaging findings in schizophrenia and psychopathology. A review of the literature relating to positive and negative symptoms. Marks RC; Luchins DJ Mod Probl Pharmacopsychiatry; 1990; 24():89-123. PubMed ID: 2186269 [No Abstract] [Full Text] [Related]
56. Family history and brain morphology in schizophrenia: an MRI study. Schwarzkopf SB; Nasrallah HA; Olson SC; Bogerts B; McLaughlin JA; Mitra T Psychiatry Res; 1991 May; 40(1):49-60. PubMed ID: 1946840 [TBL] [Abstract][Full Text] [Related]
57. Lateral ventricular size in schizophrenia: relationship to the disease process and its clinical manifestations. Owens DG; Johnstone EC; Crow TJ; Frith CD; Jagoe JR; Kreel L Psychol Med; 1985 Feb; 15(1):27-41. PubMed ID: 3991834 [TBL] [Abstract][Full Text] [Related]
58. Relationship between symptoms rated with the Positive and Negative Syndrome Scale and brain measures in schizophrenia. d'Amato T; Rochet T; Dalery J; Laurent A; Chauchat JH; Terra JL; Marie-Cardine M Psychiatry Res; 1992 Oct; 44(1):55-62. PubMed ID: 1461947 [TBL] [Abstract][Full Text] [Related]
59. Correlates of rapid neuroleptic response in male patients with schizophrenia. Petrie EC; Faustman WO; Moses JA; Lombrozo L; Csernansky JG Psychiatry Res; 1990 Aug; 33(2):171-7. PubMed ID: 2243894 [TBL] [Abstract][Full Text] [Related]
60. Stability of positive and negative symptom constructs during neuroleptic treatment in schizophrenia. Goldman RS; Tandon R; Liberzon I; Goodson J; Greden JF Psychopathology; 1991; 24(4):247-52. PubMed ID: 1754657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]